Outcomes after SynCardia® temporary total artificial heart implantation: A 20-year single-center experience in 196 patients.

While high mortality rates persist among patients with biventricular failure, the SynCardia® TAH offers a viable interim solution for critically ill patients, particularly those who can be successfully bridged to heart transplantation.